当前位置:首页 - 行情中心 - 康芝药业(300086) - 财务分析

康芝药业

(300086)

  

流通市值:29.44亿  总市值:30.40亿
流通股本:4.41亿   总股本:4.55亿

康芝药业(300086)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-0.55亿元,每股收益-0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益111019.70万元,未分配利润-31894.93万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产190481.35万元,负债79461.65万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入232,448,515.1112,416,086.22472,817,734.83363,813,064.07
营业总成本302,106,524.19126,233,165.07643,150,239.2522,876,726.08
其他经营收益
营业利润-60,689,697.11-10,056,825.06-222,347,012.53-140,561,696.09
利润总额-60,618,864.83-9,951,321.87-231,970,837.8-141,911,509.13
净利润-55,108,349.75-10,256,142.69-224,426,506.01-124,651,523.18
每股收益
其他综合收益---252,137.11-
综合收益总额-55,108,349.75-10,256,142.69-224,678,643.12-124,651,523.18
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计336,592,259.16440,262,634.94443,074,835.84522,349,018.33
非流动资产:
非流动资产合计1,568,221,233.011,572,618,695.841,532,775,713.851,565,273,119.98
资产总计1,904,813,492.172,012,881,330.781,975,850,549.692,087,622,138.31
流动负债:
流动负债合计452,688,238.38514,564,761.2495,680,547.46475,690,335.69
非流动负债:
非流动负债合计341,928,213.49343,256,862.36314,851,053.1329,643,176.11
负债合计794,616,451.87857,821,623.56810,531,600.56805,333,511.8
所有者权益(或股东权益):
归属于母公司股东权益合计1,085,827,134.571,130,227,617.531,139,922,413.011,250,594,836.81
股东权益合计1,110,197,040.31,155,059,707.221,165,318,949.131,282,288,626.51
负债和股东权益合计1,904,813,492.172,012,881,330.781,975,850,549.692,087,622,138.31
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计384,567,604.3205,002,738.01753,309,627.31526,104,289.75
经营活动现金流出小计318,215,108.54164,489,600.04681,849,701.69520,809,005.54
经营活动产生的现金流量净额66,352,495.7640,513,137.9771,459,925.625,295,284.21
投资活动产生的现金流量:
投资活动现金流入小计1,666.68-9,843,658.036,358,946.8
投资活动现金流出小计78,874,898.3673,881,504.4393,757,908.6469,924,827.17
投资活动产生的现金流量净额-78,873,231.68-73,881,504.43-83,914,250.61-63,565,880.37
筹资活动产生的现金流量:
筹资活动现金流入小计113,826,220.6860,503,915.74186,877,956.26137,377,956.26
筹资活动现金流出小计167,019,127.3747,349,622.12200,942,395.6599,811,508.23
筹资活动产生的现金流量净额-53,192,906.6913,154,293.62-14,064,439.3937,566,448.03
汇率变动对现金及现金等价物的影响-13,875.16-3,171.4652,155.9248,785.35
现金及现金等价物净增加额-65,727,517.77-20,217,244.3-26,466,608.46-20,655,362.78
期末现金及现金等价物余额47,457,968.1792,968,241.64108,177,324.4123,627,683.55
补充资料:
现金及现金等价物的净增加额-65,727,517.77--26,466,608.46-
TOP↑